Contribution of dendritic cell/T cell interactions to triggering and maintaining autoimmunity

Biological Research

Volumn 44, Issue 1, 2011, Pages 53-61

  Llanos, Carolina ^a   Carreño, Leandro J ^a   Kalergis, Alexis M ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Autoimmunity; Dendritic cells; Immunological synapse; T cells; Tolerance

Indexed keywords

ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL COMMUNICATION; DENDRITIC CELL; HUMAN; IMMUNOLOGY; T LYMPHOCYTE;

AUTOIMMUNE DISEASES; AUTOIMMUNITY; CELL COMMUNICATION; DENDRITIC CELLS; HUMANS; T-LYMPHOCYTES;

EID: 79957932100     PISSN: 07169760     EISSN: 07176287     Source Type: Journal    
DOI: 10.4067/S0716-97602011000100007     Document Type: Article

References (90)

1. BANCHEREAU, J. and R. M. STEINMAN (1998). "Dendritic cells and the control of immunity." Nature 392(6673): 245-252.
2. BERER, A., J. STOCKL, et al. (2000). "1,25-Dihydroxyvitamin D(3) inhibits dendritic cell differentiation and maturation in vitro." Exp Hematol 28(5): 575-583.
3. BERG-BROWN, N. N., M. A. GRONSKI, et al. (2004). "PKCtheta signals activation versus tolerance in vivo." J Exp Med 199(6): 743-752.
4. Bettini, M. L., and D.A. Vignali "Development of thymically derived natural regulatory T cells." Ann N Y Acad Sci 1183: 1-12.
5. BIANCO, N. R., S. H. KIM, et al. (2009). "Therapeutic effect of exosomes from indoleamine 2,3-dioxygenase-positive dendritic cells in collageninduced arthritis and delayed-type hypersensitivity disease models." Arthritis Rheum 60(2): 380-389.
6. BOUSSO, P. (2008). "T-cell activation by dendritic cells in the lymph node: lessons from the movies." Nat Rev Immunol 8(9): 675-684.
7. BRESSON, D. and M. VON HERRATH (2007). "Moving towards efficient therapies in type 1 diabetes: to combine or not to combine?" Autoimmun Rev 6(5): 315-322.
8. BRIMNES, M. K., L. BONIFAZ, et al. (2003). "Infl uenza virus-induced dendritic cell maturation is associated with the induction of strong T cell immunity to a coadministered, normally nonimmunogenic protein." J Exp Med 198(1): 133-144.
9. BRUSKO, T. M., A. L. PUTNAM, et al. (2008). "Human regulatory T cells: role in autoimmune disease and therapeutic opportunities." Immunol Rev 223: 371-390.
10. CARREÑO, L. J., P. A. GONZALEZ, et al. (2006). "Modulation of T cell function by TCR/pMHC binding kinetics." Immunobiology 211(1-2): 47-64.
11. Casciola-Rosen, L. A., G. Anhalt, et al. (1994). "Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes." J Exp Med 179(4): 1317-1330.
12. CHOY, E. H. and G. S. PANAYI (2001). "Cytokine pathways and joint infl ammation in rheumatoid arthritis." N Engl J Med 344(12): 907-916.
13. CLANCY, R. M., P. J. NEUFING, et al. (2006). "Impaired clearance of apoptotic cardiocytes is linked to anti-SSA/Ro and -SSB/La antibodies in the pathogenesis of congenital heart block." J Clin Invest 116(9): 2413-2422.
14. COFFMAN, R. L. (2006). "Origins of the T(H)1-T(H)2 model: a personal perspective." Nat Immunol 7(6): 539-541.
15. COOMBES, J. L., K. R. SIDDIQUI, et al. (2007). "A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism." J Exp Med 204(8): 1757-1764.
16. CRIADO, G., E. SIMELYTE, et al. (2009). "Indoleamine 2,3 dioxygenasemediated tryptophan catabolism regulates accumulation of Th1/Th17 cells in the joint in collagen-induced arthritis." Arthritis Rheum 60(5): 1342-1351.
17. CUA, D. J., J. SHERLOCK, et al. (2003). "Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune infl ammation of the brain." Nature 421(6924): 744-748.
18. Dall'era, M. and D. Wofsy (2009). "Systemic lupus erythematosus clinical trials-an interim analysis." Nat Rev Rheumatol 5(6): 348-351.
19. DAVIS, D. M. and M. L. DUSTIN (2004). "What is the importance of the immunological synapse?" Trends Immunol 25(6): 323-327.
20. DEANGELIS, T. and F. LUBLIN (2008). "Multiple sclerosis: new treatment trials and emerging therapeutic targets." Curr Opin Neurol 21(3): 261-271.
21. DIEBOLD, S. S. (2008). "Determination of T-cell fate by dendritic cells." Immunol Cell Biol 86(5): 389-397.
22. DUSTIN, M. L. (2008). "Hunter to gatherer and back: immunological synapses and kinapses as variations on the theme of amoeboid locomotion." Annu Rev Cell Dev Biol 24: 577-596.
23. DUSTIN, M. L. (2008). "T-cell activation through immunological synapses and kinapses." Immunol Rev 221: 77-89.
24. DUSTIN, M. L. (2009). "The cellular context of T cell signaling." Immunity 30(4): 482-92.
25. DUSTIN, M. L. and D. R. COLMAN (2002). "Neural and immunological synaptic relations." Science 298(5594): 785-789.
26. DUSTIN, M. L., M. W. OLSZOWY, et al. (1998). "A novel adaptor protein orchestrates receptor patterning and cytoskeletal polarity in T-cell contacts." Cell 94(5): 667-677.
27. DUSTIN, M. L., S. Y. TSENG, et al. (2006). "T cell-dendritic cell immunological synapses." Curr Opin Immunol 18(4): 512-516.
28. EISENBERG, R. (2009). "Why can't we fi nd a new treatment for SLE?" J Autoimmun 32(3-4): 223-230.
29. EIZIRIK, D. L., M. L. COLLI, et al. (2009). "The role of infl ammation in insulitis and beta-cell loss in type 1 diabetes." Nat Rev Endocrinol 5(4): 219-226.
30. GALLEGOS, A. M. and M. J. BEVAN (2004). "Central tolerance to tissuespecifi c antigens mediated by direct and indirect antigen presentation." J Exp Med 200(8): 1039-1049.
31. GARDNER, J. M., J. J. DEVOSS, et al. (2008). "Deletional tolerance mediated by extrathymic Aire-expressing cells." Science 321(5890): 843-847.
32. GONZALEZ, P. A., L. J. CARREÑO, et al. (2007). "Modulation of immunological synapse by membrane-bound and soluble ligands." Cytokine Growth Factor Rev 18(1-2): 19-31.
33. GONZALEZ, P. A., C. E. PRADO, et al. (2008). "Respiratory syncytial virus impairs T cell activation by preventing synapse assembly with dendritic cells." Proc Natl Acad Sci U S A 105(39): 14999-15004.
34. GORONZY, J. J. and C. M. WEYAND (2008). "T-cell co-stimulatory pathways in autoimmunity." Arthritis Res Ther 10 Suppl 1: S3.
35. GRAKOUI, A., S. K. BROMLEY, et al. (1999). "The immunological synapse: a molecular machine controlling T cell activation." Science 285(5425): 221-227.
36. GREGORI, S., N. GIARRATANA, et al. (2002). "A 1alpha,25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice." Diabetes 51(5): 1367-1374.
37. HACKSTEIN, H., A. E. MORELLI, et al. (2001). "Aspirin inhibits in vitro maturation and in vivo immunostimulatory function of murine myeloid dendritic cells." J Immunol 166(12): 7053-7062.
38. HACKSTEIN, H., T. TANER, et al. (2003). "Rapamycin inhibits IL-4-induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo." Blood 101(11): 4457-4463.
39. HACKSTEIN, H. and A. W. THOMSON (2004). "Dendritic cells: emerging pharmacological targets of immunosuppressive drugs." Nat Rev Immunol 4(1): 24-34.
40. HENRICKSON, S. E., T. R. MEMPEL, et al. (2008). "T cell sensing of antigen dose governs interactive behavior with dendritic cells and sets a threshold for T cell activation." Nat Immunol 9(3): 282-291.
41. HERRADA, A. A., F. J. CONTRERAS, et al. "Aldosterone promotes autoimmune damage by enhancing Th17-mediated immunity." J Immunol 184(1): 191-202.
42. HERRADA, A. A., F. J. CONTRERAS, et al. (2007). "Immune complexinduced enhancement of bacterial antigen presentation requires Fcgamma receptor III expression on dendritic cells." Proc Natl Acad Sci U S A 104(33): 13402-13407.
43. HORWITZ, D. A. (2008). "Regulatory T cells in systemic lupus erythematosus: past, present and future." Arthritis Res Ther 10(6): 227.
44. IRURETAGOYENA, M. I., C. A. RIEDEL, et al. (2008). "Activating and inhibitory Fcgamma receptors can differentially modulate T cellmediated autoimmunity." Eur J Immunol 38(8): 2241-2250.
45. IRURETAGOYENA, M. I., J. A. TOBAR, et al. (2005). "Andrographolide interferes with T cell activation and reduces experimental autoimmune encephalomyelitis in the mouse." J Pharmacol Exp Ther 312(1): 366-372.
46. IRURETAGOYENA, M. I., M. WIESENDANGER, et al. (2006). "The dendritic cell-T cell synapse as a determinant of autoimmune pathogenesis." Curr Pharm Des 12(2): 131-147.
47. KALERGIS, A. M. (2003). "Modulation of T cell immunity by TCR/pMHC dwell time and activating/inhibitory receptor pairs on the antigenpresenting cell." Curr Pharm Des 9(3): 233-244.
48. KALERGIS, A. M., M. I. IRURETAGOYENA, et al. (2009). "Modulation of nuclear factor-kappaB activity can infl uence the susceptibility to systemic lupus erythematosus." Immunology 128(1 Suppl): e306-e314.
49. Kalergis, A. M. and J. V. Ravetch (2002). "Inducing tumor immunity through the selective engagement of activating Fcgamma receptors on dendritic cells." J Exp Med 195(12): 1653-9.
50. KRAKOWSKI, M. and T. OWENS (1996). "Interferon-gamma confers resistance to experimental allergic encephalomyelitis." Eur J Immunol 26(7): 1641-1646.
51. LANZAVECCHIA, A. and F. SALLUSTO (2001). "Regulation of T cell immunity by dendritic cells." Cell 106(3): 263-266.
52. LE BON, A., C. THOMPSON, et al. (2006). "Cutting edge: enhancement of antibody responses through direct stimulation of B and T cells by type I IFN." J Immunol 176(4): 2074-2078.
53. LEANDRO, M. J., J. C. EDWARDS, et al. (2002). "An open study of B lymphocyte depletion in systemic lupus erythematosus." Arthritis Rheum 46(10): 2673-2677.
54. LIM, H. W., P. HILLSAMER, et al. (2005). "Cutting edge: direct suppression of B cells by CD4+ CD25+ regulatory T cells." J Immunol 175(7): 4180-4183.
55. LIU, Y. J. (2005). "IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors." Annu Rev Immunol 23: 275-306.
56. LOVGREN, T., M. L. ELORANTA, et al. (2004). "Induction of interferonalpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG." Arthritis Rheum 50(6): 1861-1872.
57. LUTZ, M. B. and C. KURTS (2009). "Induction of peripheral CD4+ T-cell tolerance and CD8+ T-cell cross-tolerance by dendritic cells." Eur J Immunol 39(9): 2325-2330.
58. MCCAUGHTRY, T. M., T. A. BALDWIN, et al. (2008). "Clonal deletion of thymocytes can occur in the cortex with no involvement of the medulla." J Exp Med 205(11): 2575-2584.
59. MERRILL, J. T., C. M. NEUWELT, et al. "Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial." Arthritis Rheum 62(1): 222-233.
60. MONK, C. R., M. SPACHIDOU, et al. (2005). "MRL/Mp CD4+,CD25- T cells show reduced sensitivity to suppression by CD4+,CD25+ regulatory T cells in vitro: a novel defect of T cell regulation in systemic lupus erythematosus." Arthritis Rheum 52(4): 1180-1184.
61. MONKS, C. R., B. A. FREIBERG, et al. (1998). "Three-dimensional segregation of supramolecular activation clusters in T cells." Nature 395(6697): 82-86.
62. MURPHY, C. A., C. L. LANGRISH, et al. (2003). "Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune infl ammation." J Exp Med 198(12): 1951-1957.
63. PETERSON, P., T. ORG, et al. (2008). "Transcriptional regulation by AIRE: molecular mechanisms of central tolerance." Nat Rev Immunol 8(12): 948-957.
64. PFEIFHOFER, C., K. KOFLER, et al. (2003). "Protein kinase C theta affects Ca2+ mobilization and NFAT cell activation in primary mouse T cells." J Exp Med 197(11): 1525-1535.
65. PIRCHER, H., U. H. ROHRER, et al. (1991). "Lower receptor avidity required for thymic clonal deletion than for effector T-cell function." Nature 351(6326): 482-485.
66. PROBST, H. C., J. LAGNEL, et al. (2003). "Inducible transgenic mice reveal resting dendritic cells as potent inducers of CD8+ T cell tolerance." Immunity 18(5): 713-720.
67. PROBST, H. C., K. MCCOY, et al. (2005). "Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4." Nat Immunol 6(3): 280-286.
68. RAHMAN, A. and D. A. ISENBERG (2008). "Systemic lupus erythematosus." N Engl J Med 358(9): 929-939.
69. Salek-Ardakani, S., T. So, et al. (2005). "Protein kinase Ctheta controls Th1 cells in experimental autoimmune encephalomyelitis." J Immunol 175(11): 7635-7641.
70. SHARPE, A. H. (2009). "Mechanisms of costimulation." Immunol Rev 229(1): 5-11.
71. SMITH, K. G., R. B. JONES, et al. (2006). "Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: Remission, relapse, and re-treatment." Arthritis Rheum 54(9): 2970-2982.
72. STARR, T. K., S. C. JAMESON, et al. (2003). "Positive and negative selection of T cells." Annu Rev Immunol 21: 139-176.
73. STEINMAN, R. M., D. HAWIGER, et al. (2003). "Tolerogenic dendritic cells." Annu Rev Immunol 21: 685-711.
74. SUN, C. M., J. A. HALL, et al. (2007). "Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid." J Exp Med 204(8): 1775-1785.
75. SUN, Z., C. W. ARENDT, et al. (2000). "PKC-theta is required for TCRinduced NF-kappaB activation in mature but not immature T lymphocytes." Nature 404(6776): 402-407.
76. TAN, S. L., J. ZHAO, et al. (2006). "Resistance to experimental autoimmune encephalomyelitis and impaired IL-17 production in protein kinase C theta-deficient mice." J Immunol 176(5): 2872-2879.
77. TAYLOR, P. C. and M. FELDMANN (2009). "Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis." Nat Rev Rheumatol 5(10): 578-582.
78. TOBAR, J. A., L. J. CARRENO, et al. (2006). "Virulent Salmonella enterica serovar typhimurium evades adaptive immunity by preventing dendritic cells from activating T cells." Infect Immun 74(11): 6438-6448.
79. TOKUNAGA, M., K. SAITO, et al. (2007). "Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system." Ann Rheum Dis 66(4): 470-475.
80. UENO, H., E. KLECHEVSKY, et al. (2007). "Dendritic cell subsets in health and disease." Immunol Rev 219: 118-142.
81. VANDENBARK, A. A. and H. OFFNER (2008). "Critical evaluation of regulatory T cells in autoimmunity: are the most potent regulatory specificities being ignored?" Immunology 125(1): 1-13.
82. VENIGALLA, R. K., T. TRETTER, et al. (2008). "Reduced CD4+,CD25- T cell sensitivity to the suppressive function of CD4+,CD25high,CD127 -/low regulatory T cells in patients with active systemic lupus erythematosus." Arthritis Rheum 58(7): 2120-2130.
83. Waldron-Lynch, F. and K. C. Herold (2009). "Advances in Type 1 diabetes therapeutics: immunomodulation and beta-cell salvage." Endocrinol Metab Clin North Am 38(2): 303-317, 8.
84. Wang, L., K. Pino-Lagos, et al. (2008). "Programmed death 1 ligand signaling regulates the generation of adaptive Foxp3+CD4+ regulatory T cells." Proc Natl Acad Sci USA 105(27): 9331-9336.
85. WEAVER, C. T., L. E. HARRINGTON, et al. (2006). "Th17: an effector CD4 T cell lineage with regulatory T cell ties." Immunity 24(6): 677-688.
86. WENINK, M. H., K. C. SANTEGOETS, et al. (2009). "The inhibitory Fc gamma IIb receptor dampens TLR4-mediated immune responses and is selectively up-regulated on dendritic cells from rheumatoid arthritis patients with quiescent disease." J Immunol 183(7): 4509-20.
87. WILLENBORG, D. O., S. FORDHAM, et al. (1996). "IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis." J Immunol 157(8): 3223-3227.
88. WINGERCHUK, D. M., C. F. LUCCHINETTI, et al. (2001). "Multiple sclerosis: current pathophysiological concepts." Lab Invest 81(3): 263-281.
89. YAMAZAKI, S., D. DUDZIAK, et al. (2008). "CD8+ CD205+ splenic dendritic cells are specialized to induce Foxp3+ regulatory T cells." J Immunol 181(10): 6923-6933.
90. YAMAZAKI, S., T. IYODA, et al. (2003). "Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells." J Exp Med 198(2): 235-247.